| 000 | 01704 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513130204.0 | ||
| 264 | 0 | _c19971106 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0022-5223 | ||
| 024 | 7 |
_a10.1016/S0022-5223(97)70053-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChen, J M | |
| 245 | 0 | 0 |
_aReevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. _h[electronic resource] |
| 260 |
_bThe Journal of thoracic and cardiovascular surgery _cOct 1997 |
||
| 300 |
_a627-34 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aCardiac Catheterization |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Transplantation _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 | _aLikelihood Functions |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitroprusside _xtherapeutic use |
| 650 | 0 | 4 |
_aPulmonary Circulation _xdrug effects |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aLevin, H R | |
| 700 | 1 | _aMichler, R E | |
| 700 | 1 | _aPrusmack, C J | |
| 700 | 1 | _aRose, E A | |
| 700 | 1 | _aAaronson, K D | |
| 773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 114 _gno. 4 _gp. 627-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0022-5223(97)70053-9 _zAvailable from publisher's website |
| 999 |
_c9310330 _d9310330 |
||